Skip to content

A prospective randomized controlled study of two procedures for the treatment of moderate volume hypertensive thalamic basal ganglia cerebral hemorrhage

A prospective randomized controlled study of two procedures for the treatment of moderate volume hypertensive thalamic basal ganglia cerebral hemorrhage

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052924
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-15
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive cerebral hemorrhage

Interventions

Group A:microscopic trans-lateral fissure surgery with a small bone window
Group B:Stereotactic soft channel puncture drainage surgery

Sponsors

The Second Affiliated Hospital of South China University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for hypertensive cerebral hemorrhage (long-term history of hypertension, and the bleeding site is a typical site of hypertension); 2. The bleeding site is located in the thalamus basal ganglia; 3. The bleeding volume is 30-60ml (including 30 and 60ml); 4. Family members receive surgical treatment; 5. Aged between 40-70 years(including 40 and 70 years old).

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart and lung, liver and kidney insufficiency that may affect the prognosis; 2. Although the bleeding volume is 30-60ml, but the patient has brain herniation; 3. The total amount of hemorrhage is 30-60ml, but it is mainly broken into the ventricle; 4. Those who participated in other clinical trials or the researchers considered that it was not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Modified Rankin score ;

Secondary

MeasureTime frame
Operation time;intraoperative blood loss;Re-bleeding rate;hematoma clearance rate;Incidence of complications;icu hospitalization time;muscle strength;linguistic function;DTI scan to measure FA values in the area of interest (lesion-side internal capsule and radiographic crown);

Countries

China

Contacts

Public ContactWang Bing

The Second Affiliated Hospital of South China University

xjtuwb@163.com+86 15273435847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026